Bionano Genomics Inc (BNGO)
0.945
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.945
0.00 (0.00%)
After-Hours: 16:02
Bionano Genomics Gross Profit Margin (Quarterly): 22.74% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 22.74% |
September 30, 2023 | 29.50% |
June 30, 2023 | 26.65% |
March 31, 2023 | 27.92% |
December 31, 2022 | 21.97% |
September 30, 2022 | 25.05% |
June 30, 2022 | 22.05% |
March 31, 2022 | 15.12% |
December 31, 2021 | 3.79% |
September 30, 2021 | 24.79% |
June 30, 2021 | 37.32% |
March 31, 2021 | 32.92% |
December 31, 2020 | 29.55% |
September 30, 2020 | 33.52% |
Date | Value |
---|---|
June 30, 2020 | 48.98% |
March 31, 2020 | 24.65% |
December 31, 2019 | 39.37% |
September 30, 2019 | 28.31% |
June 30, 2019 | 28.51% |
March 31, 2019 | 38.10% |
December 31, 2018 | 25.55% |
September 30, 2018 | -8.47% |
June 30, 2018 | 46.51% |
March 31, 2018 | 52.42% |
December 31, 2017 | 47.41% |
September 30, 2017 | 38.38% |
June 30, 2017 | 25.37% |
March 31, 2017 | 29.96% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
3.79%
Minimum
Dec 2021
48.98%
Maximum
Jun 2020
27.51%
Average
27.92%
Median
Mar 2023
Gross Profit Margin (Quarterly) Benchmarks
Bruker Corp | 50.36% |
Azenta Inc | 39.86% |
Harvard Bioscience Inc | 57.99% |
Akoya Biosciences Inc | 62.75% |
Singular Genomics Systems Inc | -42.28% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -127.6% |
Return on Assets | -91.72% |
Return on Invested Capital | -118.5% |
Profit Margin (Quarterly) | -409.4% |
Operating Margin (Quarterly) | -232.7% |
Return on Net Operating Assets | -151.7% |